![Ervin Veszprémi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ervin Veszprémi
Geen lopende functies
Profiel
Ervin Veszprémi formerly worked at Medichem SA, as Chief Executive Officer from 2003 to 2014, Invent Invest Holding SL, as Chief Executive Officer from 2015 to 2016, Genmedica Therapeutics SL, as Chairman, Kindred Biosciences, Inc., as Independent Director from 2013 to 2021, Amersham Corp., as Head-Business Unit, Novartis Groupe France SA, as Vice President, Novartis Animal Health US, Inc., as Vice President & Global Head-Marketing in 2002, and Pharmacia Spain SA, as Head-Business Unit.
Mr. Veszprémi received his undergraduate degree from the University of British Columbia.
Eerdere bekende functies van Ervin Veszprémi
| Bedrijven | Functie | Einde |
|---|---|---|
| KINDRED BIOSCIENCES, INC. | Directeur/Bestuurslid | 27-08-2021 |
Invent Invest Holding SL
 Invent Invest Holding SL Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Algemeen Directeur | 04-10-2016 |
Medichem SA
 Medichem SA Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical ingredients | Algemeen Directeur | 01-01-2014 |
Novartis Groupe France SAS
 Novartis Groupe France SAS Financial ConglomeratesFinance Functions as an investment holding company | Corporate Officer/Principal | - |
Novartis Animal Health US, Inc.
 Novartis Animal Health US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for animals | Verkoop & Marketing | 01-01-2002 |
Opleiding van Ervin Veszprémi
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
15
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Amersham Corp.
 Amersham Corp. Investment ManagersFinance Amersham Corp. focuses on the acquisition and ownership of mid-sized manufactures of precision engineered components and assemblies with particular interest in aerospace, automotive and medical device manufacturers and suppliers. The firm invests in small to medium sized companies with annual sales of $10 million to $200 million | Finance |
Kindred Biosciences, Inc.
 Kindred Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for animals | Health Technology |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Groupe France SAS
Novartis Groupe France SAS Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Genmedica Therapeutics SL
 Genmedica Therapeutics SL BiotechnologyHealth Technology Engages in the research and development of treatments for metabolic disorders | Health Technology |
Novartis Animal Health US, Inc.
Novartis Animal Health US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for animals | Health Technology |
Medichem SA
Medichem SA Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical ingredients | Health Technology |
Pharmacia Spain SA | |
Invent Invest Holding SL
Invent Invest Holding SL Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
Kies MarketScreener 
